The role of AMP-activated protein kinase in regulation of skeletal muscle metabolism;Rola kinazy białkowej aktywowanej przez AMP (AMPK) w regulacji metabolizmu miȩśni szkieletowych

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 64, Issue , 2010, Pages 513-521

  Dziewulska, Anna ^a   Dobrzyń, Paweł ^a   Dobrzyń, Agnieszka ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

AMPK; Fatty acids; Glucose; Glycogen; Skeletal muscles

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ENZYMOLOGY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; METABOLISM; REVIEW; SKELETAL MUSCLE;

AMP-ACTIVATED PROTEIN KINASES; BLOOD GLUCOSE; HOMEOSTASIS; HUMANS; MUSCLE, SKELETAL;

EID: 79952719627     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Abu-Elheiga L., Brinkley W. R., Zhong L., Chirala S. S., Woldegiorgis G., Wakil S. J.: The subcellular localization of acetyl-CoA carboxylase 2. Proc. Natl. Acad. Sci. USA, 2000;97:1444-1449 (Pubitemid 30118460)
2. Abu-Elheiga L., Matzuk M. M., Abo-Hashema K. A., Wakil S. J.: Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science, 2001;291:2613-2616 (Pubitemid 32249687)
3. Aschenbach W. G., Hirshman M. F., Fujii N., Sakamoto K., Howlett K. F., Goodyear L. J.: Effect of AICAR treatment on glycogen metabolism in skeletal muscle. Diabetes, 2002;51:567-573 (Pubitemid 34760161)
4. Barnes B. R., Marklund S., Steiler T. L., Walter M., Hjälm G., Amarger V., Mahlapuu M., Leng Y., Johansson C, Galuska D., Lindgren K., Abrink M., Stapleton D., Zierath J. R., Andersson L.: The 5'-AMP-activated protein kinase γ3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J. Biol. Chem., 2004;279:38441-38447 (Pubitemid 39295995)
5. Beg Z. H., Allmann D. W., Gibson D. M.: Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and with protein fractions of rat liver cytosol. Biochem. Biophys. Res. Commun., 1973;54:1362-1369
6. Bergeron R., Ren J. M., Cadman K. S., Moore I. K., Perret P., Pypaert M., Young L. H., Semenkovich C. F., Shulman G. I.: Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am. J. Physiol. Endocrinol. Metab., 2001;281:E1340-E1346
7. Bonen A., Dyck D. J., Ibrahimi A., Abumrad N. A.: Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36. Am. J. Physiol., 1999;276:E642-E649 (Pubitemid 29211335)
8. Bonen A., Luiken J. J., Arumugam Y., Glatz J. F., Tandon N. N.: Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J. Biol. Chem., 2000;275:14501-14508 (Pubitemid 30339737)
9. Bruss M. D., Arias E. B., Lienhard G. E., Cartee G. D.: Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes, 2005;54:41-50 (Pubitemid 40105093)
10. Carling D., Hardie D. G.: The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. Biochim. Biophys. Acta, 1989;1012:81-86 (Pubitemid 19154923)
11. Carlson C. A., Kim K. H.: Regulation of hepatic acetyl coenzyme A carboxylase by phosphorylation and dephosphorylation. J. Biol. Chem., 1973;248:378-380
12. Chavez J. A., Roach W. G., Keller S. R., Lane W. S., Lienhard G. E.: Inhibition of GLUT4 translocation by Tbc1d1, a Rab GTPase-activating protein abundant in skeletal muscle, is partially relieved by AMP-activated protein kinase activation. J. Biol. Chem., 2008;283:9187-9195
13. Corton J. M., Gillespie J. G., Hardie D. G.: Role of the AMP-activated protein kinase in the cellular stress response. Curr. Biol., 1994;4:315-324
14. Devlin J. T., Horton E. S.: Effects of prior high-intensity exercise on glucose metabolism in normal and insulin-resistant men. Diabetes, 1985;34:973-979 (Pubitemid 16236515)
15. Dobrzyn A., Dobrzyn P.: Stearoyl-CoA desaturase - a new player in skeletal muscle metabolism regulation. J. Physiol. Pharmacol., 2006;57(Suppl. 10):31-42 (Pubitemid 46548765)
16. Dobrzyn A., Dobrzyn P., Miyazaki M., Ntambi J. M.: Polyunsaturated fatty acids do not activate AMP-activated protein kinase in mouse tissues. Biochem. Biophys. Res. Commun., 2005;332:892-896 (Pubitemid 40745197)
17. Dobrzyn P., Dobrzyn A., Miyazaki M., Cohen P., Asilmaz E., Hardie D. G., Friedman J. M., Ntambi J. M.: Stearoyl-CoA desaturase 1 defciency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc. Natl. Acad. Sci. USA, 2004;101:6409-6414 (Pubitemid 38585987)
18. Drew B. G., Fidge N. H., Gallon-Beaumier G., Kemp B. E., Kingwell B. A.: High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc. Natl. Acad. Sci. USA, 2004;101:6999-7004 (Pubitemid 38596432)
19. Fryer L. G., Parbu-Patel A., Carling D.: The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem., 2002;277:25226-25232 (Pubitemid 34951829)
20. Geraghty K. M., Chen S., Harthill J. E., Ibrahim A. F., Toth R., Morrice N. A., Vandermoere F., Moorhead G. B., Hardie D. G., MacKintosh C: Regulation of multisite phosphorylation and 14-3-3 binding of AS 160 in response to IGF-1, EGF, PMA and AICAR. Biochem. J., 2007;407:231-241 (Pubitemid 47556988)
21. Glund S., Deshmukh A., Long Y. C., Moller T., Koistinen H. A., Caidahl K., Zierath J. R., Krook A.: Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes, 2007;56:1630-1637 (Pubitemid 46842596)
22. Goodyear L. J., Kahn B. B.: Exercise, glucose transport, and insulin sensitivity. Annu. Rev. Med., 1998;49:235-261 (Pubitemid 28197452)
23. Hada Y., Yamauchi T., Waki H., Tsuchida A., Hara K., Yago H., Miyazaki O., Ebinuma H., Kadowaki T.: Selective purification and characterization of adiponectin multimer species from human plasma. Biochem. Biophys. Res. Commun., 2007;356:487-493 (Pubitemid 46454397)
24. Han R., Lai R., Ding Q., Wang Z., Luo X., Zhang Y., Cui G., He J., Liu W., Chen Y.: Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism. Diabetologia, 2007;50:1960-1968 (Pubitemid 47222866)
25. 2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J. Biol. Chem., 1995;270:27186-27191
26. Horman S., Vertommen D., Heath R., Neumann D., Mouton V., Woods A., Schlattner U., Wallimann T., Carling D., Hue L., Rider M. H.: Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase α-subunits in heart via hierarchical phosphorylation of Ser485/491. J. Biol. Chem., 2006;281:5335-5340 (Pubitemid 43847626)
27. Hulver M. W., Berggren J. R., Carper M. J., Miyazaki M., Ntambi J. M., Hoffman E. P., Thyfault J. P., Stevens R., Dohm G. L., Houmard J. A., Muoio D. M.: Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab., 2005;2:251-261
28. Jäger S., Handschin C, St-Pierre J., Spiegelman B. M.: AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc. Natl. Acad. Sci. USA, 2007;104:12017-12022 (Pubitemid 47185622)
29. Jakobsen S. N., Hardie D. G., Morrice N., Tornqvist H. E.: 5'-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J. Biol. Chem., 2001;276:46912-46916
30. Janovská A., Hatzinikolas G., Staikopoulos V., McInerney J., Mano M., Wittert G. A.: AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity. Mol. Cell. Endocrinol., 2008;284:1-10
31. Jensen T. E., Rose A. J., Jorgensen S. B., Brandt N., Schjerling P., Wojtaszewski J. F., Richter E. A.: Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction. Am. J. Physiol. Endocrinol. Metab., 2007;292:E1308-E1317 (Pubitemid 46684599)
32. Jorgensen S. B., Nielsen J. N., Birk J. B., Olsen G. S., Viollet B., Andreelli F., Schjerling P., Vaulont S., Hardie D. G., Hansen B. F., Richter E. A., Wojtaszewski J. F.: The α2-5' AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. Diabetes, 2004;53:3074-3081 (Pubitemid 39564481)
33. Jorgensen S. B., Treebak J. T., Viollet B., Schjerling P., Vaulont S., Wojtaszewski J. F., Richter E. A.: Role of AMPKα2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle. Am. J. Physiol. Endocrinol. Metab., 2007;292:E331-E339 (Pubitemid 46052958)
34. Jorgensen S. B., Viollet B., Andreelli F., Frosig C, Birk J. B., Schjerling P., Vaulont S., Richter E. A., Wojtaszewski J. F.: Knockout of the α2 but not α1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebutnot contractioninduced glucose uptake in skeletal muscle. J. Biol. Chem., 2004;279:1070-1079 (Pubitemid 38082628)
35. Koh H. J., Arnolds D. E., Fujii N., Tran T. T., Rogers M. J., Jessen N., Li Y., Liew C. W., Ho R. C., Hirshman M. F., Kulkarni R. N., Kahn C. R., Goodyear L. J.: Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol. Cell. Biol., 2006;26:8217-8227 (Pubitemid 44748559)
36. Kramer H. F., Witczak C. A., Fujii N., Jessen N., Taylor E. B., Arnolds D. E., Sakamoto K., Hirshman M. F., Goodyear L. J.: Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes, 2006;55:2067-2076 (Pubitemid 44509981)
37. Kurth-Kraczek E. J., Hirshman M. F., Goodyear L. J., Winder W. W.: 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes, 1999;48:1667-1671 (Pubitemid 29356879)
38. Li L., Chen H., McGee S. L.: Mechanism of AMPK regulating GLUT4 gene expression in skeletal muscle cells. Sheng Wu Yi Xue Gong Cheng XueZaZhi, 2008;25:161-167
39. Long Y. C., Barnes B. R., Mahlapuu M., Steiler T. L., Martinsson S., Leng Y., Wallberg-Henriksson H., Andersson L., Zierath J. R.: Role of AMP-activated protein kinase in the coordinated expression of genes controlling glucose and lipid metabolism in mouse white skeletal muscle. Diabetologia, 2005;48:2354-2364 (Pubitemid 41618928)
40. McBride A., Hardie D. G.: AMP-activated protein kinase - a sensor of glycogen as well as AMP and ATP? Acta Physiol., 2009;196:99-113
41. McGee S. L., Howlett K. F., Starkie R. L., Cameron-Smith D., Kemp B. E., Hargreaves M.: Exercise increases nuclear AMPK alpha2 in human skeletal muscle. Diabetes, 2003;52:926-928 (Pubitemid 36384261)
42. Minokoshi Y., Kim Y. B., Peroni O. D., Fryer L. G., Müller C, Carling D., Kahn B. B.: Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature, 2002;415:339-343 (Pubitemid 34087557)
43. Mora S., Pessin J. E.: The MEF2A isoform is required for striated muscle-specific expression of the insulin-responsive GLUT4 glucose transporter. J. Biol. Chem., 2000;275:16323-16328 (Pubitemid 30366948)
44. Morris D. L., Rui L.: Recent advances in understanding leptin signaling and leptin resistance. Am. J. Physiol. Endocrinol. Metab., 2009;297:E1247-E1259
45. Muoio D. M., Dohm G. L., Fiedorek F. T. Jr., Tapscott E. B., Coleman R. A.: Leptin directly alters lipid partitioning in skeletal muscle. Diabetes, 1997;46:1360-1363 (Pubitemid 27315287)
46. Murrant C. L., Reid M. B.: Detection of reactive oxygen and reactive nitrogen species in skeletal muscle. Microsc. Res. Tech., 2001;55:236-248 (Pubitemid 33136323)
47. Musi N., Goodyear L. J.: AMP-activated protein kinase and muscle glucose uptake. Acta Physiol. Scand., 2003;178:337-345 (Pubitemid 36960424)
48. Nielsen J. N., Wojtaszewski J. F.: Regulation of glycogen synthase activity and phosphorylation by exercise. Proc. Nutr. Soc, 2004;63:233-237 (Pubitemid 38787471)
49. Nieto-Vazquez I., Fernández-Veledo S., de Alvaro C, Lorenzo M.: Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle. Diabetes, 2008;57:3211-3221
50. Pehmoller C, Treebak J. T., Birk J. B., Chen S., Mackintosh C, Hardie D. G., Richter E. A., Wojtaszewski J. F.: Genetic disruption of AMPK signaling abolishes both contraction-and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle. Am. J. Physiol. Endocrinol. Metab., 2009;297:E665-E675
51. Pimenta A. S., Gaidhu M. P., Habib S., So M., Fediuc S., Mirpourian M., Musheev M., Curi R., Ceddia R. B.: Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells. J. Cell. Physiol., 2008;217:478-485
52. Rafaeloff-Phail R., Ding L., Conner L., Yeh W. K., McClure D., Guo H., Emerson K., Brooks H.: Biochemical regulation of mammalian AMP-activated protein kinase activity by NAD and NADH. J. Biol. Chem., 2004;279:52934-52939 (Pubitemid 40051792)
53. Roepstorff C, Vistisen B., Donsmark M., Nielsen J. N., Galbo H., Green K. A., Hardie D. G., Wojtaszewski J. F., Richter E. A., Kiens B.: Regulation of hormone-sensitive lipase activity and Ser563 and Ser565 phosphorylation in human skeletal muscle during exercise. J. Physiol., 2004;560:551-562 (Pubitemid 39445335)
54. Roman E. A., Reis D., Romanatto T, Maimoni D., Ferreira E. A., Santos G. A., Torsoni A. S., Velloso L. A., Torsoni M. A.: Central leptin action improves skeletal muscle AKT, AMPK, and PGC1 α activation by hypothalamic PI3K-dependent mechanism. Mol. Cell. Endocrinol., 2010;314:62-69
55. Saitoh M., Pullen N., Brennan P, Cantrell D., Dennis P. B., Thomas G.: Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J. Biol. Chem., 2002;277:20104-20112 (Pubitemid 34967534)
56. Sakamoto K., Holman G. D.: Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffc. Am. J. Physiol. Endocrinol. Metab., 2008;295:E29-E37
57. Sampath H., Ntambi J. M.: The fate and intermediary metabolism of stearic acid. Lipids, 2005;40:1187-1191 (Pubitemid 43117841)
58. Sanders M. J., Grondin P. O., Hegarty B. D., Snowden M. A., Carling D.: Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J., 2007;403:139-148 (Pubitemid 46569875)
59. Sandström M. E., Zhang S. J., Bruton J., Silva J. P, Reid M. B., Westerblad H., Katz A.: Role of reactive oxygen species in contraction-mediated glucose transport in mouse skeletal muscle. J. Physiol., 2006;575:251-262 (Pubitemid 44178142)
60. Scott J. W., Hawley S. A., Green K. A., Anis M., Stewart G., Scullion G. A., Norman D. G., Hardie D. G.: CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J. Clin. Invest., 2004;113:274-284 (Pubitemid 38544212)
61. Sim A. T., Hardie D. G.: The low activity of acetyl-CoA carboxylase in basal and glucagon-stimulated hepatocytes is due to phosphorylation by the AMP-activated protein kinase and not cyclic AMP-dependent protein kinase. FEBS Lett., 1988;233:294-298
62. Smith A. C., Bruce C. R., Dyck DJ.: AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle. J. Physiol., 2005;565:547-553 (Pubitemid 40872481)
63. Steinberg G. R., Michell B. J., van Denderen B. J., Watt M. J., Carey A. L., Fam B. C., Andrikopoulos S., Proietto J., Görgün C. Z., Carling D., Hotamisligil G. S., Febbraio M. A., Kay T. W., Kemp B. E.: Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab., 2006;4:465-474 (Pubitemid 44834113)
64. Steinberg G. R., Rush J. W., Dyck D. J.: AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment. Am. J. Physiol. Endocrinol. Metab., 2003;284:E648-E654 (Pubitemid 36237554)
65. Steinberg G. R., Smith A. C., Van Denderen B. J., Chen Z., Murthy S., Campbell D. J., Heigenhauser G. J., Dyck D. J., Kemp B. E.: AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females. J. Clin. Endocrinol. Metab., 2004;89:4575-4580 (Pubitemid 39244472)
66. Suter M., Riek U., Tuerk R., Schlattner U., Wallimann T., Neumann D.: Dissecting the role of 5'-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J. Biol. Chem., 2006;281:32207-32216 (Pubitemid 46036775)
67. Towler M. C., Hardie D. G.: AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res., 2007;100:328-341
68. Toyoda T, Hayashi T, Miyamoto L., Yonemitsu S., Nakano M., Tanaka S., Ebihara K., Masuzaki H., Hosoda K., Inoue G., Otaka A., Sato K., Fushiki T., Nakao K.: Possible involvement of the alpha1 isoform of 5 AMP-activated protein kinase in oxidative stress-stimulated glucose transport in skeletal muscle. Am. J. Physiol. Endocrinol. Metab., 2004;287:E166-E173 (Pubitemid 38856297)
69. Treebak J. T., Glund S., Deshmukh A., Klein D. K., Long Y. C., Jensen T. E., Jorgensen S. B., Viollet B., Andersson L., Neumann D., Wallimann T, Richter E. A., Chibalin A. V., Zierath J. R., Wojtaszewski J. F.: AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes, 2006;55:2051-2058 (Pubitemid 44509979)
70. Tremblay F., Brule S., Hee Um S., Li Y., Masuda K., Roden M., Sun X. J., Krebs M., Polakiewicz R. D., Thomas G., Marette A.: Identification of IRS-1 Ser-1101 asa target of S6K1 in nutrient-and obesity-induced insulin resistance. Proc. Natl. Acad. Sci. USA, 2007;104:14056-14061 (Pubitemid 350003334)
71. Verhoeven A. J., Woods A., Brennan C. H., Hawley S. A., Hardie D. G., Scott J., Beri R. K., Carling D.: The AMP-activated protein kinase gene is highly expressed in rat skeletal muscle. Alternative splicing and tissue distribution of the mRNA. Eur. J. Biochem., 1995;228:236-243
72. Viollet B., Lantier L., Devin-Leclerc J., Hebrard S., Amouyal C, Mounier R., Foretz M., Andreelli F: Targeting the AMPK pathway for the treatment of Type 2 diabetes. Front. Biosci., 2009;14:3380-3400
73. Wang C, Mao X., Wang L., Liu M., Wetzel M. D., Guan K. L., Dong L. Q., Liu F.: Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1. J. Biol. Chem., 2007;282:7991-7996 (Pubitemid 47093602)
74. Wang Y., Li X., Guo Y., Chan L., Guan X.: α-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-γ coactivator-α signaling in the skeletal muscle of aged mice. Metabolism, 2010;59:967-976
75. Watt M. J., Dzamko N., Thomas W. G., Rose-John S., Ernst M., Carling D., Kemp B. E., Febbraio M. A., Steinberg G. R.: CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat. Med., 2006;12:541-548
76. Watt M. J., Holmes A. G., Pinnamaneni S. K., Garnham A. P., Steinberg G. R., Kemp B. E., Febbraio M. A.: Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am. J. Physiol. Endocrinol. Metab., 2006;290:E500-E508 (Pubitemid 43671697)
77. Watt M. J., Steinberg G. R., Chen Z. P., Kemp B. E., Febbraio M. A.: Fatty acids stimulate AMP-activated protein kinase and enhance fatty acid oxidation in L6 myotubes. J. Physiol., 2006;574:139-147 (Pubitemid 43905803)
78. Winder W. W., Hardie D. G.: Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am. J. Physiol., 1996;270:E299-E304
79. Winder W. W., Holmes B. F., Rubink D. S., Jensen E. B., Chen M., Holloszy J. O.: Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J. Appl. Physiol., 2000;88:2219-2226 (Pubitemid 30453931)
80. Winder WW., Thomson D. M.: Cellular energy sensing and signaling by AMP-activated protein kinase. Cell Biochem. Biophys., 2007;47:332-347 (Pubitemid 47339850)
81. 2+/calmodulin-dependent protein kinase kinase-alpha regulates skeletal muscle glucose uptake independent of AMP-activated protein kinase and Akt activation. Diabetes, 2007;56:1403-1409 (Pubitemid 46715632)
82. Witczak C. A., Sharoff C. G., Goodyear L. J.: AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell. Mol. Life Sci., 2008;65:3737-3755
83. Woods A., Johnstone S. R., Dickerson K., Leiper F. C., Fryer L. G., Neumann D., Schlattner U., Wallimann T., Carlson M., Carling D.: LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol., 2003;13:2004-2008 (Pubitemid 37425212)
84. Xiao B., Heath R., Saiu P., Leiper F. C., Leone P., Jing C, Walker PA., Haire L., Eccleston J. F., Davis C. T., Martin S. R., Carling D., Gamblin S. J.: Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature, 2007;449:496-500 (Pubitemid 47509548)
85. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., Okada-Iwabu M., Kawamoto S., Kubota N., Kubota T., Ito Y., Kamon J., Tsuchida A., Kumagai K, Kozono H., Hada Y, Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Awazawa M., Takamoto I., Froguel P., Hara K., Tobe K, Nagai R., Ueki K., Kadowaki T.: Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med., 2007;13:332-339 (Pubitemid 46376688)
86. Young M. E., Radda G. K., Leighton B.: Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR - an activator of AMP-activated protein kinase. FEBS Lett., 1996;382:43-47 (Pubitemid 26092941)
87. Zhou G., Sebhat I. K., Zhang B. B.: AMPK activators - potential therapeutics for metabolic and other diseases. Acta Physiol., 2009;196:175-190